DE69518159D1 - Mittel zur vorsorge und heilung von typ i allergischen krankheiten - Google Patents

Mittel zur vorsorge und heilung von typ i allergischen krankheiten

Info

Publication number
DE69518159D1
DE69518159D1 DE69518159T DE69518159T DE69518159D1 DE 69518159 D1 DE69518159 D1 DE 69518159D1 DE 69518159 T DE69518159 T DE 69518159T DE 69518159 T DE69518159 T DE 69518159T DE 69518159 D1 DE69518159 D1 DE 69518159D1
Authority
DE
Germany
Prior art keywords
branched
linear
allergic diseases
type
cure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69518159T
Other languages
English (en)
Other versions
DE69518159T2 (de
Inventor
Yukio Amano
Yuko Mizushima
Kenji Ogata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis UK Holdings Ltd
Original Assignee
Aventis Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Ltd filed Critical Aventis Pharma Ltd
Publication of DE69518159D1 publication Critical patent/DE69518159D1/de
Application granted granted Critical
Publication of DE69518159T2 publication Critical patent/DE69518159T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69518159T 1994-10-17 1995-10-04 Mittel zur vorsorge und heilung von typ i allergischen krankheiten Expired - Fee Related DE69518159T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25029394 1994-10-17
PCT/JP1995/002027 WO1996011682A1 (fr) 1994-10-17 1995-10-04 Composition preventive et remede pour les maladies allergiques de type i

Publications (2)

Publication Number Publication Date
DE69518159D1 true DE69518159D1 (de) 2000-08-31
DE69518159T2 DE69518159T2 (de) 2002-01-03

Family

ID=17205757

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69518159T Expired - Fee Related DE69518159T2 (de) 1994-10-17 1995-10-04 Mittel zur vorsorge und heilung von typ i allergischen krankheiten

Country Status (19)

Country Link
US (1) US5814649A (de)
EP (1) EP0787491B1 (de)
KR (1) KR100365064B1 (de)
AT (1) ATE194912T1 (de)
AU (1) AU695907B2 (de)
CA (1) CA2202904C (de)
DE (1) DE69518159T2 (de)
DK (1) DK0787491T3 (de)
ES (1) ES2148561T3 (de)
FI (1) FI971584A (de)
GR (1) GR3034413T3 (de)
HU (1) HU222888B1 (de)
IL (1) IL115617A (de)
NO (1) NO315928B1 (de)
NZ (1) NZ293691A (de)
PT (1) PT787491E (de)
TW (1) TW429146B (de)
WO (1) WO1996011682A1 (de)
ZA (1) ZA958708B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE196764T1 (de) * 1997-08-08 2000-10-15 Aventis Pharma Gmbh Kristallform von 5-methylisoxazol-4-carbonsäure- (4-trifluormethyl)-anilid
WO1999042446A1 (fr) 1998-02-19 1999-08-26 Kowa Co., Ltd. Composes cycliques d'amide
US6303652B1 (en) * 1998-08-21 2001-10-16 Hughes Institute BTK inhibitors and methods for their identification and use
WO2002034251A1 (en) * 2000-10-20 2002-05-02 Parker Hughes Institute Treatment of asthma with lfm analogues
WO2001051008A2 (en) * 2000-01-07 2001-07-19 University Of Cincinnati Selective activation of a th1 or th2 lymphocyte regulated immune response
US6849260B2 (en) 2000-08-18 2005-02-01 Amgen Inc. Methods and compositions for treating IgE-related disease using NNT-1 inhibitors
US6890940B2 (en) 2001-06-29 2005-05-10 Kowa Co., Ltd. Bis(2-aryl-5-pyridyl) derivatives
US6706703B2 (en) 2001-06-29 2004-03-16 Kowa Co., Ltd. Bis(5-aryl-2-pyridyl) derivatives
US8283515B2 (en) 2002-05-03 2012-10-09 Sca Hygiene Products Ab Absorbent article containing a skin conditioning agent
CA2772275A1 (en) 2009-09-18 2011-03-24 Sanofi (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2854439A1 (de) * 1978-12-16 1980-07-03 Hoechst Ag Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
DD297328A5 (de) * 1989-08-18 1992-01-09 �������@���������k���Kk�� 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
US5001124A (en) * 1990-02-02 1991-03-19 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
DE4127737A1 (de) * 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
TW314467B (de) * 1993-03-31 1997-09-01 Hoechst Ag

Also Published As

Publication number Publication date
CA2202904C (en) 2006-12-19
HUT77135A (hu) 1998-03-02
NO971743D0 (no) 1997-04-16
FI971584A0 (fi) 1997-04-15
NZ293691A (en) 1999-07-29
KR970706811A (ko) 1997-12-01
EP0787491A4 (de) 1998-09-30
IL115617A (en) 1999-11-30
ATE194912T1 (de) 2000-08-15
DK0787491T3 (da) 2000-10-16
NO315928B1 (no) 2003-11-17
US5814649A (en) 1998-09-29
ES2148561T3 (es) 2000-10-16
PT787491E (pt) 2000-11-30
AU695907B2 (en) 1998-08-27
NO971743L (no) 1997-04-16
FI971584A (fi) 1997-04-15
DE69518159T2 (de) 2002-01-03
GR3034413T3 (en) 2000-12-29
WO1996011682A1 (fr) 1996-04-25
KR100365064B1 (ko) 2003-04-11
AU3618695A (en) 1996-05-06
TW429146B (en) 2001-04-11
EP0787491A1 (de) 1997-08-06
EP0787491B1 (de) 2000-07-26
IL115617A0 (en) 1996-01-19
ZA958708B (en) 1996-05-14
CA2202904A1 (en) 1996-04-25
HU222888B1 (hu) 2003-12-29

Similar Documents

Publication Publication Date Title
DE69529670T2 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
ATE384524T1 (de) Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis
GEP20063831B (en) Substituted bicyclic derivatives for treatment of abnormal cell growth
DE69518159D1 (de) Mittel zur vorsorge und heilung von typ i allergischen krankheiten
DE69707372T2 (de) Verwendung eines Phosphorsäurediesters zur Herstellung eines Arzneimittels zur Behandlung von Akne
DE69402004T2 (de) Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen
AU7424394A (en) 3- or 4-glycosyloxybenzopyran derivatives and antiallergic agents containing the derivatives as active ingredients
ATE258229T1 (de) Substanz fa-70d, herstellungsverfahren und verwendungen
ATE204294T1 (de) Thiol derivate mit metallopeptidase inhibierender aktivitat
DE69619088T2 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
DE69910706D1 (de) Medikament zur Behandlung von Glaukoma und ischämischer Retinopathie
DE69327077D1 (de) Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
IT1277736B1 (it) Derivati tiolici ad attivita&#39; inibitrice delle metallopeptidasi
ATE223418T1 (de) 4&#39;-substituierte-4&#39;,5&#39;-dihydropsoralene und deren therapeutische verwendung

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8339 Ceased/non-payment of the annual fee